Cambridge Investment Research Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-104	Closed	-$2K	–	3322
2023 Q3	$2K	Buy	+104	New	+$2.71K	﹤0.01%	3130
2022 Q4	–	Sell	-4	Closed	-$2K	–	3234
2022 Q3	$2K	Hold	4	–	–	﹤0.01%	3048
2022 Q2	$3K	Hold	4	–	–	﹤0.01%	3038
2022 Q1	$9K	Hold	4	–	–	﹤0.01%	3145
2021 Q4	$10K	Hold	4	–	–	﹤0.01%	3151
2021 Q3	$18K	Buy	4 +1	+33%	+$5.03K	﹤0.01%	3061
2021 Q2	$20K	Sell	3 -1	-25%	-$6.46K	﹤0.01%	3065
2021 Q1	$29K	Buy	4 +1	+33%	+$10.6K	﹤0.01%	2832
2020 Q4	$18K	Buy	3 +1	+50%	+$6.12K	﹤0.01%	2689
2020 Q3	$16K	Sell	2 -1	-33%	-$7.41K	﹤0.01%	2499
2020 Q2	$16K	Buy	3 +1	+50%	+$4.25K	﹤0.01%	2438
2020 Q1	$8K	Hold	2	–	–	﹤0.01%	2261
2019 Q4	$14K	Buy	+2	New	+$18.9K	﹤0.01%	2391

Other funds holding TTOO

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cambridge Investment Research Advisors's TTOO Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 104 shares — an estimated $2K sold.

Cambridge Investment Research Advisors first reported a position in TTOO in Q4 2019 and held it in 13 quarters. The position peaked at $29K in Q1 2021. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

Cambridge Investment Research Advisors reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
Cambridge Investment Research Advisors sold 104 T2 Biosystems, Inc shares in Q4 2023, an estimated $2K.
Cambridge Investment Research Advisors first reported a position in T2 Biosystems, Inc in Q4 2019 and held it in 13 quarters.
Cambridge Investment Research Advisors's T2 Biosystems, Inc position peaked at $29K in Q1 2021.
21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.